GENinCode plc (GENI)の価格はいくらですか

GENinCode plc (GENI)の価格は$0.01156596です

GENinCode plc (GENI)の時価総額は何ですか

GENinCode plc (GENI)の時価総額は$32.34Kです

GENinCode plc（GENI）PBR（株価純資産倍率）

GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.

年	P/B比率	変化
提供された日付のデータは十分ではありません。

年

P/B比率

変化

提供された日付のデータは十分ではありません。

企業	P/B比率	P/B比率の差	国
Thermo Fisher Scientific Inc. TMO.US	4.0441	-	US
Danaher Corporation DHR.US	2.6166	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
IDEXX Laboratories, Inc. IDXX.US	28.7765	-	US
Natera, Inc. NTRA.US	21.3575	-	US

企業

P/B比率

P/B比率の差

国